Do women remain at risk even if they do not inherit a familial BRCA1/2 mutation?
- PMID: 22042956
- DOI: 10.1200/JCO.2011.37.6483
Do women remain at risk even if they do not inherit a familial BRCA1/2 mutation?
Comment on
-
Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry.J Clin Oncol. 2011 Dec 1;29(34):4505-9. doi: 10.1200/JCO.2010.34.4440. Epub 2011 Oct 31. J Clin Oncol. 2011. PMID: 22042950 Free PMC article.
Similar articles
-
BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1863-70. doi: 10.1158/1055-9965.EPI-06-0258. Epub 2006 Oct 4. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17021353
-
Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry.Breast Cancer Res Treat. 2015 Jun;151(3):653-60. doi: 10.1007/s10549-015-3419-y. Epub 2015 May 15. Breast Cancer Res Treat. 2015. PMID: 25975955 Free PMC article.
-
The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas.Clin Genet. 2014 Jan;85(1):64-7. doi: 10.1111/cge.12132. Epub 2013 Apr 5. Clin Genet. 2014. PMID: 23458327
-
Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries.J Med Genet. 2016 Jan;53(1):15-23. doi: 10.1136/jmedgenet-2015-103132. Epub 2015 Jul 17. J Med Genet. 2016. PMID: 26187060 Free PMC article. Review.
-
Reproductive factors and breast cancer risk among BRCA1 or BRCA2 mutation carriers: results from ten studies.Cancer Epidemiol. 2014 Feb;38(1):1-8. doi: 10.1016/j.canep.2013.11.004. Epub 2013 Dec 12. Cancer Epidemiol. 2014. PMID: 24332935 Review.
Cited by
-
Survey of primary care physicians' views about breast and ovarian cancer screening for true BRCA1/2 non-carriers.J Community Genet. 2020 Apr;11(2):205-213. doi: 10.1007/s12687-019-00438-3. Epub 2019 Oct 28. J Community Genet. 2020. PMID: 31659621 Free PMC article.
-
Somatic variants of potential clinical significance in the tumors of BRCA phenocopies.Hered Cancer Clin Pract. 2019 Jul 16;17:21. doi: 10.1186/s13053-019-0117-5. eCollection 2019. Hered Cancer Clin Pract. 2019. PMID: 31346352 Free PMC article.
-
Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?PLoS One. 2018 Apr 16;13(4):e0195497. doi: 10.1371/journal.pone.0195497. eCollection 2018. PLoS One. 2018. PMID: 29659587 Free PMC article.
-
No evidence of excessive cancer screening in female noncarriers from BRCA1/2 mutation-positive families.Curr Oncol. 2017 Dec;24(6):352-359. doi: 10.3747/co.24.3759. Epub 2017 Dec 20. Curr Oncol. 2017. PMID: 29270046 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
